Dementia and Alzheimer Disease

Epilepsy

Headache and Migraine

Movement Disorders

Multiple Sclerosis

Neuromuscular

Sleep Disorders

Stroke

News

Media

All Videos

Medical World News

Podcasts

Weekly Recap

Cure Connections

Insights

News Network

NeurologyLive Peer Exchange

Conferences

Conference Coverage

Conference Listing

CME/CE

Partners

Publications

NeurologyLive

International Journal of MS Care

Resources

Disease Spotlight

Fellows' Corner

Future Leaders in Neurology

Giants of Multiple Sclerosis

Interactive Tools

Live Events

Neurology Resources

Virtual Events

Subscribe

eNewsletter

Print Subscription

Articles

A web-based survey of Korean neurologists interested in narcolepsy presented their concerns with using the multiple sleep latency test, noting that it may lead to ambiguous results due to accompanying sleep disorders like sleep apnea. 

Polysomnography More Commonly Used in Narcolepsy Detection Prior to Multiple Sleep Latency Test 

A single dose of ubrogepant at its highest FDA-approved strength of 60 mg once daily had no statistically significant effect on atogepant pharmacokinetics.

Combination of CRGP Antagonists Ubrogepant and Atogepant Proves Safe in Phase 1b Trial

Videos

Neurology News Network for the week ending February 4, 2023. [WATCH TIME: 4 minutes]

New Diagnostic Criteria Established for MOGAD, FDA Approves Proclaim XR SCS System, Clinical Hold on IKT-148009 Lifted

The clinical psychologist from Ayer Neuroscience Institute at Hartford Healthcare Headache Center shared some highlights from her recently published survey study on migraine treatment during pregnancy. 

Knowledge and Comfort in Treating Migraine During Pregnancy

The chief training and education officer at the Parkinson’s Foundation discussed the importance of educating healthcare professionals on different specialists that play a role in Parkinson disease management. [WATCH TIME: 2 minutes]

Educating and Diversifying Clinicians to Help Overcome Gaps in Parkinson Disease Management: Eli Pollard

The director of the Montefiore Einstein Center for the Aging Brain provided insight on expanding the use of the 5-Cog tool, and whether it can be used for other conditions like HIV or COVID-19. [WATCH TIME: 3 minutes]

Adopting the 5-Cog Assessment Nationally, Other Cognitive Conditions: Joe Verghese, MBBS, MS

The chief training and education officer at the Parkinson’s Foundation provided perspective on the vast types of medical professionals who can learn from the organization’s new education series. [WATCH TIME: 4 minutes]

Educating and Easing Interdisciplinary Care Teams to Treat Parkinson Disease: Eli Pollard

, has been with the team since October 2019. Follow him on Twitter 

Donald Whiting, MD, chair of Allegheny Health Network’s Neurosciences Institute, provided insight on ADvance II, a multinational trial exploring the use of deep brain stimulation in patients with mild Alzheimer disease. 

Using Deep Brain Stimulation to Treat Alzheimer Disease Symptoms

NeurologyLive is your direct connection to the latest neurology news and interviews with expert neurologists in multimedia formats.

About Us

Advisory Board

Editorial

Contact Us

Advertise

Contact MJH LS

Do Not Sell My Information

Terms and Conditions

Privacy

NeurologyLive – Clinical Neurology News and Neurology Expert Insights

Facebook

Twitter

LinkedIN

Spotlight

NMOSD

Narcolepsy

Parkinson Disease

Clinical Focus

Dementia/Alzheimer

Headache/Migraine

Video Series

 Peer Exchange video series features panels of expert physicians engaging in in-depth discussions about practice-changing treatments, challenges in care, and the future paradigm of management for neurologic diseases.

Peer Exchange

1rem

Management of Narcolepsy and Excessive Daytime Sleepiness

Overview of Excessive Daytime Sleepiness 

Overview of Narcolepsy

Signs and Symptoms of Narcolepsy

Narcolepsy Type 1 and Type 2

 Diagnosis of Narcolepsy

Goals of Therapy in Narcolepsy

Nonpharmacologic Therapies for Narcolepsy

Laboratory Testing in Patients with Narcolepsy

Traditional Treatments for Narcolepsy

Pitolisant: Recently FDA Approved for Narcolepsy

Solriamfetol: Recently FDA Approved for Narcolepsy

Deciding Which Drug to Use in Narcolepsy

Insurance Coverage For Drugs to Treat Narcolepsy

Patient Resources Including the Narcolepsy Network 

Drugs in Development for Treatment of Narcolepsy

Unmet Needs in the Treatment of Narcolepsy

Advice for Community Physicians Treating Narcolepsy

Referral to a Sleep Specialist to Treat Narcolepsy

Final Thoughts on Treating Narcolepsy